Project Details

Perform another search<<First  <Prev [5226 of 5967Next>  Last>>

CWSF 2006 - Saguenay, Québec

Print/Download as PDF

Yale Michaels

A Potential New Approach to Chemotherapy in Brain Cancer: Disruption of Connexion 43 Particle Arrang
Division:Life Sciences
Region:Winnipeg Schools
City:Winnipeg, MB
School:Grant Park High
Abstract:Malignant Glioma is the most common human brain tumour with an average 15 month survival. This poor prognosis can be attributed to the ineffectiveness of adjuvant therapies, such as radiation and chemotherapy. My research focused on the importance of gap junction intercellular communication (GJIC) on cell death induced by chemotherapy in malignant glioma. I found that inhibiting GJIC improved cell killing by Temozolomide chemotherapy.

Awards Value
The University of Western Ontario Scholarship
Gold Medallist - $2000 Entrance Scholarship
Sponsor: University of Western Ontario
$2 000.00
Gold Medal - Health Sciences
Sponsor: Canadian Institutes of Health Research
$1 500.00
Total$3 500.00